arrow
W

William Sievert

monash university
H指数:47
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA-C)
2024-08-020
OAAI
High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy
2024-07-154
OAAI
Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care
2023-12-191
OAAI
Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants
2023-08-019
OAAI
Combination treatments including the small-interfering RNA JNJ-3989 induce rapid and sometimes prolonged viral responses in patients with CHB
2022-11-0152
OA
Hepatitis B Virus Flares After Nucleot(s)ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling Pathways

Nucleot(s)ide类似物停止后乙型肝炎病毒耀斑与Toll样受体信号通路的激活有关

2022-09-153
PRE
Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels

在非肝硬化HBeAg阴性慢性乙型肝炎患者中停止nucleot(s)ide类似物: 96周时HBsAg消失与低基线HBsAg水平相关

2022-05-0627
PRE
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

丙型肝炎病毒患病率的全球变化以及护理2015年和2020的级联: 一项建模研究

2022-05-01368
OAAI
Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients With Difficult to Cure Characteristics
2020-09-0524
OAAI